Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin

被引:8
|
作者
dos Reis Serra, Cristina Helena [1 ]
Chang, Kyung Hee [2 ]
Dezani, Thaisa Marinho [1 ]
Porta, Valentina [1 ]
Storpirtis, Silvia [1 ]
机构
[1] Univ Sao Paulo, Dept Pharm, Sao Paulo, SP, Brazil
[2] Libbs Pharmaceut, Sao Paulo, SP, Brazil
关键词
Tablets/formulations/bioequivalence study; Cephalexin/dissolution efficiency; ORAL CEPHALOSPORINS; EXCRETION DATA; PHARMACOKINETICS; BIOAVAILABILITY; COMPARTMENT; ABSORPTION; PLASMA;
D O I
10.1590/S1984-82502015000200016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulation). Dissolution efficiency (DE%) was calculated for both formulations to evaluate their in vitro biopharmaceutical features. The oral bioequivalence study was performed in twenty-four healthy volunteers in a crossover design. Single oral dose (tablet containing 500 mg of cephalexin) of each product was administered with two weeks of washout period. Urinary concentrations of cephalexin were measured by high-performance liquid chromatography (HPLC) method and pharmacokinetics parameters were estimated by urinary excretion data. The bioequivalence was determined by the following parameters: the cumulative amount of cephalexin excreted in the urine, the total amount of cephalexin excreted in the urine and the maximum urinary excretion rate of cephalexin. DE values of immediate-release cephalexin tablets (500 mg) were 68.69 +/- 4.18% for product A and 71.03 +/- 6.63% for product B. Regarding the dissolution test of the two brands (A and B) analysed, both were in compliance with the official pharmacopeial specifications, since the dissolution of both formulations was superior to 80% of the amount declared in the label after 45 minutes of test (A=92.09%+/- 1.84; B=92.84%+/- 1.08). The results obtained indicated that the products A and B are pharmaceutical equivalents. Confidence intervals for the pharmacokinetic parameters were in compliance with the international standards, indicating that products A and B can be considered bioequivalents and, therefore, interchangeable.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 50 条
  • [41] Steady-state bioequivalence studies of two memantine tablet and oral solution formulations in healthy volunteers
    Chladek, Jaroslav
    Zaludek, Borek
    Sova, Petr
    Franc, Ales
    Sispera, Ludek
    Martinkova, Jirina
    Micuda, Stanislav
    Cermanova, Jolana
    JOURNAL OF APPLIED BIOMEDICINE, 2008, 6 (01): : 39 - 45
  • [42] Bioequivalence evaluation of two sertraline tablet formulations in healthy male volunteers after a single dose administration
    Zhu, CJ
    Wu, JF
    Qu, ZW
    Chen, LM
    Zhang, JT
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (03) : 120 - 124
  • [43] Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers
    Georgarakis, M
    Tsakalof, A
    Zougrou, F
    Kontopoulos, G
    Tsiptsios, I
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (01): : 15 - 19
  • [44] Comparative bioavailability study with two gemfibrozil tablet formulations in healthy volunteers
    Borges, NCD
    Mendes, GD
    Barrientos-Astigarraga, RE
    Zappi, E
    Mendes, FD
    De Nucci, G
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (07): : 382 - 386
  • [45] Evaluation of the Bioequivalence of Two Tablet Formulations of Enalapril after Single Oral Administration to Chinese Healthy Volunteers
    Song, Ji-jun
    Gao, Jian
    Shi, Sheng-li
    Tian, Dong-dong
    Yin, Wei-yong
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (06): : 942 - 947
  • [46] Comparative Pharmacokinetics and Bioequivalence of Two 50 mg Atenolol Tablet Formulations in Healthy Korean Male Volunteers
    Chang, M. J.
    Shin, W. G.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (09): : 410 - 413
  • [47] Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers
    Khorana, N.
    Maphanta, S.
    Lohitnavy, O.
    Srichaiya, A.
    Sayasathid, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (06) : 409 - 414
  • [48] Evaluation of the bioequivalence of two tablet formulations of enalapril/hydrochlorothiazide after single oral administration to healthy volunteers
    Niopas, L
    Daftsios, AC
    Nikolaidis, N
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (03): : 160 - 165
  • [49] Comparative Bioavailability study with two chlorpropamide tablet formulations in healthy volunteers
    Da Silva, Marcia Aparecida
    Mendes, Fabiana D.
    De Oliveira, Rogrio Antonio
    Monif, Thusif
    Patni, Anil
    Reyar, Sirnrit
    Mendes, Gustavo D.
    De Nucci, Gilberto
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2007, 57 (09): : 591 - 598
  • [50] Bioequivalence of two aceclofenac tablet formulations after a single oral dose to healthy male Korean volunteers
    Kim, YG
    Lee, YJ
    Kim, HJ
    Lee, SD
    Kwon, JW
    Kim, WB
    Shim, CK
    Lee, MG
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (02) : 83 - 88